HIT Consultant July 8, 2025
What You Should Know:
– Certara, a global leader in model-informed drug development, today announced an expanded collaboration with Merck, known as MSD outside of the United States and Canada.
– The strategic agreement will see Merck increase its use of the Certara Pinnacle 21 software platform to include a metadata repository and data standards workflow management. This builds upon Merck’s existing technology collaboration with Certara aimed at aiding regulatory submissions.
Addressing Data Standardization Challenges in Modern Clinical Trials
The process of transforming raw data into validated, analysis-ready datasets has become increasingly complex in modern drug development. This challenge is amplified by the sheer volume of data collected; Phase III clinical trials now average 3.6...







